At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 50 target
Drug / intervention
WMTother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Washed Microbiota Transplantation for Type 1 Diabetes Mellitus: a Real World Research
The Second Hospital of Nanjing Medical University·observational·Posted Feb 13, 2024·Updated Sep 10, 2025
In Brief
An observational study evaluating WMT for Type 1 Diabetes. Currently recruiting, targeting 50 participants across 1 site.
Detailed Summary
This is a real-world study to explore the safety and the efficacy of washed microbiota transplantation (WMT) for patients with Type 1 Diabetes Mellitus (T1DM).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesChina
Collaborators--
Timeline
N/ARecruiting
202420252026202720282029
First PostedFeb 2024
Enrollment StartMar 2024
TodayJul 2026
Primary CompletionJan 2029
Study CompletionJul 2029
First PostedFeb 13, 2024
Enrollment StartMar 1, 2024
Primary CompletionJan 1, 2029
Study CompletionJul 1, 2029
TodayJul 1, 2026
Enrollment to primary: 4.8 yearsPosted 2.4 years agoPrimary completion in 2.5 years
Interventions
WMTother
Washed microbiota transplantation refers to the infusion of washed microbiota from healthy donor into patients' gastrointestinal tract. Participants will receive three doses of WMT for T1DM.